Skip to main content
On Demand

Addressing Sickle Cell Disease Across the Age Spectrum: Current Therapies and Future Directions


Total Credits: 1 including 1 AOA Category 1-A Credit(s)

Average Rating:
   114
State Associations:
TOMA - Texas
Faculty:
Oluwaseun Olaiya, DO
Duration:
53 Minutes
Expiration:
Never expires.


Description

During this presentation, the speaker will review the clinical manifestations of sickle cell disease (SCD) and discuss the current therapies available for adult and pediatric patients with SCD.

Upon completion of this program, participants will be able to:

  1. Describe the clinical presentation and complications of Sickle Cell Disease
  2. Summarize the current therapies for patients with Sickle Cell Disease
  3. Briefly discuss the future therapies for Sickle Cell Disease

Statement of Accreditation
The Texas Osteopathic Medical Association (TOMA) is accredited by the American Osteopathic Association to provide osteopathic continuing medical education for physicians. TOMA designates this program for a maximum of 1 AOA Category 1-A credits and will report CME credits commensurate with the extent of the physician’s participation in this activity.

Grievance Policy
All grievances may be directed to TOMA's Executive Director at toma@txosteo.org. All grievances will receive an initial response within 30 days of receipt.  If the participant does not receive a satisfactory response, they can submit a complaint to the Bureau of Osteopathic Education of the AOA at 142 East Ontario Street, Chicago, IL 60611.

Handouts

Faculty

Oluwaseun Olaiya, DO's Profile

Oluwaseun Olaiya, DO Related Seminars and Products


Dr. Kemi Olaiya joined Sam Houston State University in September 2020 and is an Assistant Professor of Internal Medicine and Pediatrics at the College of Osteopathic Medicine.
She earned her Bachelor of Science degree in Biology from Texas A&M University and her medical degree from Texas College of Osteopathic Medicine at the University of North Texas Health Science Center (UNTHSC-TCOM). She completed a 4-year combined Internal Medicine-Pediatrics residency training at the University of Illinois College of Medicine at Peoria (UICOMP) and served as one of the IM/Peds chiefs. During this time, Dr. Olaiya was recognized for her teaching and scholarly activity with a Resident Teaching Award as well as a Scholar Recognition Award. She subsequently completed a 3-year fellowship in pediatric hematology and oncology at Children’s Mercy Hospital in Kansas City, MO.
Dr. Olaiya is board certified in both Internal Medicine, Pediatrics and Pediatric Hematology/Oncology and has experience in both outpatient and inpatient medicine.  She has a passion for non-malignant hematology, the adolescent and young adult population- particularly those with Sickle Cell Disease as well as Hemostasis & Thrombosis disorders. She aims to improve access to hematology care for patients by bringing her IM/Peds and hematology background to the primary care setting. Dr. Olaiya also has an interest in Clinical and Quality Improvement research. She has several publications in peer reviewed journals and has presented her scholarly work at various national and regional conferences. Dr. Olaiya recognizes the role that physicians play in health advocacy and plans to continue to pursue opportunities to address health inequities through research, community involvement and clinical care.

Dr. Olaiya discloses that she has no relevant financial relationships with any organization producing, marketing, reselling, or distributing health care goods or services consumed by, or used on, patients relative to the content of this presentation.


Reviews

5
4
3
2
1

Overall:      4.6

Total Reviews: 114